GALECTIN THERAPEUTICS INC — Director's Dealing 2015

Jul 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2015-03-12

Reporting Person: MAULDIN JOHN F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-12	Common Stock	A	11112	—	Acquired	17186	Direct
2015-04-08	Common Stock	A	25483	—	Acquired	42669	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-08	Stock Option (right to buy)	$8.10	D	14815	Disposed	2021-06-02	Common Stock (14815)	Direct
2015-04-08	Stock Option (right to buy)	$3.59	D	16714	Disposed	2023-03-28	Common Stock (16714)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4947	Indirect

Footnotes

F1: The option vested quarterly in eight equal installments beginning September 2, 2011.

F2: The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 25,483 shares of restricted common stock, reported in Table 1 of this Form 4, as consideration for the cancellation of options granted on June 2, 2011 and March 28, 2013.

F3: The option vested quarterly in eight equal installments beginning on May 12, 2013.